Luigi Mangione Withdraws Planned Psychiatric Defense Ahead Of Murder Trial

6 hours ago
Luigi Mangione has withdrawn a planned psychiatric defense in the high-profile murder case involving the killing of UnitedHealthcare CEO Brian Thompson, just months before his trial is scheduled to begin.

Mangione's attorneys informed a New York judge that they are no longer pursuing a defense based on claims that he was suffering from an extreme emotional disturbance at the time of the December 2024 shooting. The reversal came just one day after defense lawyers indicated they intended to use the argument at trial.

Had the defense moved forward, Mangione would have effectively acknowledged responsibility for Thompson's death while arguing mitigating circumstances. Under New York law, a successful extreme emotional disturbance defense can reduce a murder conviction to manslaughter, carrying a significantly lighter sentence.

Mangione, 28, has pleaded not guilty to both state and federal charges. He is accused of fatally shooting Thompson outside a Manhattan hotel as the executive was heading to a corporate event. Prosecutors allege evidence recovered after Mangione's arrest, including a 3D-printed handgun and writings criticizing the health insurance industry, links him to the killing.

The reason for the sudden change in legal strategy has not been publicly disclosed. Mangione's attorneys have not commented on the decision.

His state murder trial is scheduled to begin in September, while a separate federal case is expected to go to trial later in the fall. The case has drawn national attention because of both the victim's prominence and the unusual circumstances surrounding the investigation and arrest.